4//SEC Filing
Dubin Glenn 4
Accession 0001209191-21-059526
CIK 0001662579other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:55 PM ET
Size
7.3 KB
Accession
0001209191-21-059526
Insider Transaction Report
Form 4
Dubin Glenn
Director
Transactions
- Award
Common Stock
2021-10-04$44.99/sh+138$6,209→ 295 total
Holdings
- 20,000(indirect: By Foundation)
Common Stock
- 770,607(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021.
- [F3]Shares held directly by DF Investment Partners LLC ("DFIP"). The Reporting Person serves as managing member of DFIP and may be deemed to exercise voting and investment power over the shares held by DFIP. The Reporting Person disclaims beneficial ownership of the shares held by DFIP except to the extent of his pecuniary interest therein.
- [F4]Shares held directly by G&E Dubin Family Foundation. The Reporting Person may be deemed to exercise voting and investment power over the shares held by G&E Dubin Family Foundation and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001308597
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:55 PM ET
- Size
- 7.3 KB